echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Science News > Whole genome sequencing improves rare disease diagnosis rate

    Whole genome sequencing improves rare disease diagnosis rate

    • Last Update: 2021-12-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    One out of every 4,300 people suffers from mitochondrial diseases, which can cause progressive incurable diseases


    Recently, a new study by British researchers has brought hope to patients who have not yet been diagnosed


    Although previous studies based on small, highly selective cohorts have shown that WGS can identify mitochondrial diseases, this is the first time its effectiveness has been tested in the national healthcare system


    The study involved 319 families with suspected mitochondrial diseases, with a total of 345 participants, ranging in age from 0 to 92 years old, with an average age of 25 years old, all of which were sequenced


    Surprisingly, 62.


    Professor Patrick Chinnery, Professor of the Mitochondrial Biology Research Group of the British Medical Research Council and the Department of Clinical Neurosciences at the University of Cambridge, said: "We recommend that whole genome sequencing should be provided as soon as possible before invasive tests such as muscle biopsy


    Among the researchers' diagnosis results, 37.


    Impaired mitochondrial function often affects tissues that require high energy, such as the brain, peripheral nerves, and heart


    Chinnery said: "These patients are referred for suspected mitochondrial diseases, and traditional diagnostic tests are specifically for mitochondrial diseases


    Chinnery said that diagnostic services in the UK are fragmented and unevenly distributed, which poses major challenges for patients with rare diseases and their families


    Related research results: https://doi.


    https://doi.
    org/10.
    1136/bmj-2021-066288
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.